CymaBay Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CymaBay Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q4 2023.
  • CymaBay Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2023 was 114M shares, a 34.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 114M +29.2M +34.5% Dec 31, 2023 10-K 2024-02-28
Q3 2023 113M +28.6M +33.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 97.8M +13.1M +15.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 97.3M +12.7M +14.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 84.7M +3.12K +0% Dec 31, 2022 10-K 2024-02-28
Q3 2022 84.7M +15.7M +22.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 84.7M +15.7M +22.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 84.7M +15.7M +22.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 84.7M +15.7M +22.8% Dec 31, 2021 10-K 2023-03-23
Q3 2021 68.9M +59K +0.09% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 68.9M +59K +0.09% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 68.9M +63.6K +0.09% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 68.9M +63.6K +0.09% Dec 31, 2020 10-K 2022-03-17
Q3 2020 68.9M +186K +0.27% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 68.9M +186K +0.27% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 68.9M +188K +0.27% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 68.9M +9.43M +15.9% Dec 31, 2019 10-K 2021-03-25
Q3 2019 68.7M +9.26M +15.6% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 68.7M +9.74M +16.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 68.7M +9.98M +17% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 59.5M +15M +33.9% Dec 31, 2018 10-K 2020-03-16
Q3 2018 59.4M +15.6M +35.6% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 59M +30.2M +105% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 58.7M +30M +104% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 44.4M +21M +89.4% Dec 31, 2017 10-K 2019-02-28
Q3 2017 43.8M +20.4M +87% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 28.8M +5.31M +22.6% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 28.8M +5.31M +22.6% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 23.4M 0 0% Dec 31, 2016 10-K 2018-03-15
Q3 2016 23.4M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 23.4M +8.19M +53.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 23.4M +8.2M +53.8% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 23.4M +8.75M +59.5% Dec 31, 2015 10-K 2017-03-23
Q3 2015 23.4M +8.76M +59.7% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 15.3M +5.19M +51.6% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 15.2M +5.18M +51.5% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 14.7M +5.24M +55.4% Dec 31, 2014 10-K 2016-03-29
Q3 2014 14.7M +5.89M +67% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 10.1M Jun 30, 2014 10-Q 2014-08-14
Q1 2014 10.1M Mar 31, 2014 10-Q 2014-05-15
Q4 2013 9.46M +9.45M +163144% Dec 31, 2013 10-K 2015-03-23
Q3 2013 8.79M Sep 30, 2013 10-Q/A 2013-12-16
Q4 2012 5.79K* Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.